Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas

Acta Cytologica

Volumn 52, Issue 2, 2008, Pages 133-138

  Yantiss, Rhonda K ^a   Cosar, Ediz ^b   Fischer, Andrew H ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b University of Massachusetts   (United States)

Author keywords

CRD BP; IGF2BP; Immunohistochemistry; KOC; L523S

Indexed keywords

INSULIN LIKE GROWTH FACTOR II MRNA BINDING PROTEIN 3; ONCOFETAL ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; TUMOR CELL; ULTRASOUND;

EID: 41149098189     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325470     Document Type: Article

References (25)

1. Solcia E, Capella C, Kloppel G: Tumors of the exocrine pancreas. In Tumors of the Pancreas. Fascicle 20. Third edition. Edited by J Rosai, H Leslie. Washington DC, Armed Forces Institute of Pathology, 1997, pp 41-145
2. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U: MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003;99:365-371
3. McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, Van Heek NT, Hruban RH, Wilentz RE: Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003;11:238-243
4. Mueller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Hameister H, Varga G, Friess H, Buchler M, Beger HG, Vila MR, Adler G, Gress TM: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997;14:2729-2733
5. Wang T, Fan L, Watanabe Y, McNeill PD, Moulton GG, Bangur C, Fanger GR, Okada M, Inoue Y, Persing DH, Reed SG: L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003;88:887-894
6. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC: A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-1270
7. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K: KOC (K homology domain containing protein overexpressed in cancer): A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005;29:188-195
8. Fahey C, Bedrosian UK: Collodion bag: A cell block technique for enhanced cell collection. Lab Med 1993;74:94-96
9. Itoi T, Takei K, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Nakamura K, Moriyasu F, Tsuchida A, Kasuya K: Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses. Oncol Rep 2005;13:229-234
10. Tada M, Komatsu Y, Kawabe T, Sasahira N, Isayama H, Toda N, Shiratori Y, Omata M: Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: Clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002;97:2263-2270
11. Jhala N, Jhala D, Vickers SM, Eltoum I, Batra SK, Manne U, Eloubeidi M, Jones JJ, Grizzle WE: Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 2006;126:572-579
12. Kiledjian M, Wang X, Liebhaber SA: Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J 1995;14:4357-4364
13. Takimoto M, Tomonaga T, Matunis M, Avigan M, Krutzsch H, Dreyfuss G, Levens D: Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J Biol Chem 1993;268:18249-18258
14. Nielsen FC, Nielsen J, Christiansen J: A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest (Suppl) 2001;234:93-99
15. Liu HM, Potter EL: Development of the human pancreas. Arch Pathol 1962;74:439-532
16. Mueller-Pillasch F, Pohl B, Wilda M, Lacher U, Beil M, Wallrapp C, Hameister H, Knochel W, Adler G, Gress TM: Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999;88:95-99
17. Wagner M, Kunsch S, Duerschmied D, Beil M, Adler G, Mueller F, Gress TM: Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. Gastroenterology 2003;124:1901-1914
18. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A: Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 1997;11:3128-3142
19. Sun FL, Dean WL, Kelsey G, Allen ND, Reik W: Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 1997;389:809-815
20. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, Maher ER, Reik W: An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: Interaction between genotype and epigenotype. Hum Mol Genet 2004;13:247-255
21. Butler MG: Imprinting disorders: Non-Mendelian mechanisms affecting growth. J Pediatr Endocrinol Metab (suppl 5) 2002;15:1279-1288
22. Jouvenot Y, Ginjala V, Zhang L, Liu PQ, Oshimura M, Feinberg AP, Wolffe AP, Ohlsson R, Gregory PD: Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors. Gene Ther 2003;10:513-522
23. Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Buchler M, Adler G, Lehrach H: A pancreatic cancer-specific expression profile. Oncogene 1996;13:1819-1830
24. Jiang ZC, Chu PG, Woda BA, Rock KL, Liu Q, Hsieh CC, Li C, Chen W, Duan HO, McDougal S, Wu CL: Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal cell carcinoma: A retrospective study. Lancet Oncol 2006;7:556-564
25. Mueller F, Bommer M, Lacher U, Ruhland C, Stagge V, Adler G, Gress TM, Seufferlein T: KOC is a novel molecular indicator of malignancy. Br J Cancer 2003;88:699-701